Literature DB >> 21933304

Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection.

A L Bañuls1, P Bastien, C Pomares, J Arevalo, R Fisa, M Hide.   

Abstract

This review gives an update of current knowledge on the clinical pleiomorphism of Leishmania, with a special emphasis on the case of asymptomatic carriage. The first part describes the numerous unusual expressions of the disease that occur besides the classic (visceral, cutaneous, and mucocutaneous) forms of leishmaniases. The second part deals with progress in the understanding of disease outcome in humans, and the possible future approaches to improve our knowledge in the field. The third part highlights the role of the too often neglected asymptomatic carrier compartment. This group could be key to understanding infraspecific differences in virulence and pathogenicity of the parasite, as well as identifying the genetic determinants involved in the expression of the disease.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21933304     DOI: 10.1111/j.1469-0691.2011.03640.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  41 in total

1.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

2.  Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.

Authors:  Michael A Mandell; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 3.  Leishmaniasis in Thailand: A Review of Causative Agents and Situations.

Authors:  Saovanee Leelayoova; Suradej Siripattanapipong; Jipada Manomat; Phunlerd Piyaraj; Peerapan Tan-Ariya; Lertwut Bualert; Mathirut Mungthin
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

4.  Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase.

Authors:  John I Robinson; Stephen M Beverley
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

5.  Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.

Authors:  Erin A Brettmann; Jahangheer S Shaik; Haroun Zangger; Lon-Fye Lye; F Matthew Kuhlmann; Natalia S Akopyants; Dayna M Oschwald; Katherine L Owens; Suzanne M Hickerson; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-18       Impact factor: 11.205

6.  Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.

Authors:  Amel Ghouila; Fatma Z Guerfali; Chiraz Atri; Aymen Bali; Hanene Attia; Rabiaa M Sghaier; Ghada Mkannez; Nicholas J Dickens; Dhafer Laouini
Journal:  Infect Genet Evol       Date:  2016-11-04       Impact factor: 3.342

7.  In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis.

Authors:  Elly Montrieux; Wilmer H Perera; Marley García; Louis Maes; Paul Cos; Lianet Monzote
Journal:  Parasitol Res       Date:  2014-06-07       Impact factor: 2.289

8.  Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.

Authors:  Ranadhir Dey; Pradeep K Dagur; Angamuthu Selvapandiyan; J Philip McCoy; Poonam Salotra; Robert Duncan; Hira L Nakhasi
Journal:  J Immunol       Date:  2013-01-21       Impact factor: 5.422

9.  Wild gorillas as a potential reservoir of Leishmania major.

Authors:  Ibrahim Hamad; Claire-Lise Forestier; Martine Peeters; Eric Delaporte; Didier Raoult; Fadi Bittar
Journal:  J Infect Dis       Date:  2014-07-07       Impact factor: 5.226

10.  Case Report: Diffuse Cutaneous Leishmaniasis by Leishmania infantum in a Patient Undergoing Immunosuppressive Therapy: Risk Status in an Endemic Mediterranean Area.

Authors:  M Magdalena Alcover; Vicenç Rocamora; M Carmen Guillén; Diana Berenguer; Marta Cuadrado; Cristina Riera; Roser Fisa
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.